Moberg Pharma AB (publ)
F:MB8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Moberg Pharma AB (publ)
F:MB8
|
SE |
|
C
|
China Overseas Land & Investment Ltd
F:CPP
|
HK |
|
Sofina SA
XBRU:SOF
|
BE |
|
I
|
IPD Group Ltd
ASX:IPG
|
AU |
|
BASF SE
F:BAS
|
DE |
|
Alexander's Inc
F:AXE
|
US |
Intrinsic Value
Is MB8 undervalued or overvalued?
See the intrinsic value estimate for 
Moberg Pharma AB (publ) and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Moberg Pharma AB Does
Moberg Pharma is a Swedish specialty pharmaceutical company that develops and sells branded over-the-counter treatments, mainly for nail and skin problems such as nail fungus. Its products are designed for self-care, so the company is focused on treatments people can buy without a doctor’s prescription. It also works with partners and distributors to sell its brands in different markets.
- Headquarters
- Sweden SE
- IPO date
- May 26, 2011
Revenue & Expenses Breakdown
Moberg Pharma AB (publ)
Earnings Waterfall
Moberg Pharma AB (publ)
The intrinsic value for Moberg Pharma AB (publ) (MB8) under the Base Case is hidden EUR.
Compared with the current market price of 0.944 EUR, the stock appears hidden.